However, in the glucose drinking group there was a significant progress in adipose tissue insulin sensitivity, high-sensitivity C-reactive protein (hs-CRP), and in LDL oxidation, suggesting that fructose reduction improves markers of CVD despite the lack of recovery in hepatic steatosis [27]. The gene discussed is INS; the disease is Hepatic steatosis.